Lyell Immunopharma Balance Sheet (2020-2026) | LYEL

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
393.50M293.83M222.60M205.74M116.31M123.55M109.43M224.37M286.21M145.65M125.65M133.42M100.30M105.60M120.33M98.80M123.58M60.18M90.77M72.98M
Prepaid Assets (Quarter)
12.23M11.49M11.79M11.21M11.61M11.14M11.63M10.66M11.42M8.46M7.87M8.71M9.50M9.07M8.00M5.42M8.58M13.72M13.28M9.44M
Current Assets (Quarter)
631.15M626.29M625.71M666.78M659.75M651.29M624.40M606.41M586.85M554.69M534.16M499.82M450.05M379.59M309.18M282.21M328.20M260.94M267.30M213.54M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
115.86M120.10M125.71M127.56M125.73M123.02M118.60M113.68M108.10M102.65M97.84M93.10M88.05M48.20M44.20M39.12M36.72M34.77M32.72M30.51M
Long-Term Investments (Quarter)
36.40M47.00M47.00M47.00M42.00M44.92M10.00M36.95M32.00M32.00M19.00M19.00M19.00M13.01M19.00M19.00M19.00M6.95M23.90M
Other Non-Current Assets (Quarter)
0.47M0.47M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.29M0.29M0.29M4.62M1.69M1.58M2.54M1.58M1.59M5.84M
Non-Current Assets (Quarter)
567.19M501.12M446.40M354.90M317.52M286.27M256.05M228.94M208.13M195.34M160.06M154.32M169.17M111.27M120.62M103.24M79.76M79.11M83.32M97.61M
Assets (Quarter)
1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M340.05M350.63M311.15M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M2.89M5.47M3.88M
Payables (Quarter)
3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M2.89M5.47M3.88M
Accumulated Expenses (Quarter)
25.06M29.06M22.69M21.40M23.57M28.75M22.42M24.83M29.65M28.13M24.91M25.67M29.01M40.82M31.17M28.00M29.31M46.52M31.48M35.99M
Current Deferred Revenue (Quarter)
5.58M4.99M6.22M15.43M11.19M
Total Current Liabilities (Quarter)
59.28M46.74M41.05M50.29M51.22M37.03M30.80M34.39M35.06M34.52M32.35M30.88M33.51M53.79M41.28M36.90M31.88M49.41M36.95M39.87M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
81.88M79.67M77.87M32.93M37.16M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
65.68M66.65M68.81M67.55M64.64M63.17M66.64M66.07M64.64M56.89M55.16M60.22M58.58M50.99M57.09M55.11M53.07M41.92M39.49M46.60M
Other Non-Current Liabilities (Quarter)
5.01M4.57M4.45M4.34M4.23M4.11M4.00M3.89M3.78M3.66M3.55M3.44M3.56M3.25M3.14M5.53M2.68M0.52M0.53M0.54M
Total Non-Current Liabilities (Quarter)
206.85M193.05M186.40M149.29M153.02M100.20M92.62M94.61M93.64M91.41M87.51M84.20M84.95M104.78M90.14M81.00M76.16M91.33M76.43M76.80M
Total Liabilities (Quarter)
211.86M197.62M190.85M153.63M157.24M104.31M96.62M98.50M97.42M95.08M91.06M87.64M88.52M108.03M93.28M86.53M78.84M91.85M76.96M77.34M
Shareholder's Equity
Common Equity (Quarter)
986.47M929.79M881.25M868.04M820.03M833.25M783.83M736.86M697.57M654.95M603.16M566.50M530.70M382.82M336.52M298.92M329.12M248.20M273.67M233.81M
Liabilities and Shareholders Equity (Quarter)
1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M340.05M350.63M311.15M
Retained Earnings (Quarter)
-500.66M-1.62M-6.60M-688.83M-10.00M-767.48M-834.44M-2.38M-1.18M-0.09M1,666.32M-0.40M0.76M-1345.11M-1397.30M1,738.85M1,807.75M0.24M-0.01M1,922.43M
Treasury Shares (Quarter)
3.58M1.63M1.25M0.99M0.87M2.61M2.62M2.78M2.70M5.17M4.43M0.14M9.11M0.38M0.08M0.31M0.04M0.52M